bcr/abl has elevated tyropathways that we are now trying to define. Constitutive downstream activation of critical pathways in susceptible early prosine kinase activity that is essential for its transforming activity. We recently reported a prominent 62 kDa GAP-associagenitors that normally require KL or other factors for activation could explain most if not all features of the disease. ted P-tyr protein and five additional consistent but less prominent P-tyr proteins as well as five more minor P-tyr proteins Keywords: CML; discordant maturation; cytokine signaling pathways; kit ligand/c-kit; p210 bcr/abl tyrosine kinase activity; constitutive that are constitutively tyrosine phosphorylated in primary primitive lineage negative (lin−) chronic phase CML blasts but tyrosine phosphorylation not in comparable primary lin− normal blasts. The GAP-associated p62 protein has now been purified, sequenced and its gene has been cloned; it is a previously unidentified protein
Introduction and is currently being characterized. In analyzing P-tyr proteins in primary lin− normal blasts in response to various hematopoietic cytokines, we found a striking similarity in the tyrosine
Ever since chronic myelogenous leukemia (CML) was first phosphorylation of four major and three minor proteins after described as a specific disease entity 150 years ago, (t(9;22)(q34; q11). 11 In this translocation, the c-abl oncogene responsive to sustained bcr/abl-induced phorphorylation of a number of signaling proteins that are components of critical is transposed from its normal position on chromosome 9 (q34) regulatory pathways, including c-kit. The affected pathways to a 5.8 kb major breakpoint cluster region (M-bcr) on chrocontrol and coordinate multiple diverse cell processes includmosome 22q11, forming a fusion bcr/abl gene. [12] [13] [14] [15] The ing proliferation, differentiation, maturation and apoptosis, probcr/abl gene transcribes a novel 8.5 kb mRNA which in turn cesses that are normally tightly regulated and integrated. Perencodes a p210 kDa protein which, unlike the normal c-abl turbation of these key pathways in primitive progenitors would protein, is phosphorylated on tyrosine, and has increased intrinbe expected to seriously disrupt orderly hematopoiesis and could also explain the multiple subtle pleiotropic biological sic protein tyrosine kinase activity compared to that of the norabnormalities characteristically observed in later maturing CML mal c-abl protein. [16] [17] Because the tyrosine kinase activity of compartments that we have collectively designated 'discordant the Abelson murine leukemia virus product, p160 v-abl , is known to be necessary for cellular transformation, 18 it was suggested that the p210 bcr/abl tyrosine kinase may have an important role suggestion. [22] [23] [24] [25] [26] the most common fusion protein and most frequently causes have failed to validate that most leukemic clusters have an infectious origin, or even to provide convincing evidence that classical CML but can also be associated with ALL, AML (usually FAB M4 or M5) or rarely other diseases such as essenthey do not occur merely by chance. Other theories that have been proposed over the years to tial thrombocythemia. The largest BCR-Abl fusion protein, p230 bcr/abl (-bcr), includes over 90% of BCR amino acids, explain the myeloid expansion in CML have been more rapid proliferation of the leukemic cells, unregulated proliferation or lacking only the C-terminal two-thirds of the GAP rac domain, and appears to cause chronic neutrophilic leukemia (CML-N), increased self renewal of Ph-positive stem and/or progenitor cells, 55, 56 prolonged life span of CML leukocytes [57] [58] [59] and, a rare indolent myeloproliferative disease. [28] [29] [30] [31] The evidence is now quite compelling that CML is a clonal more recently, reduced cell death by apoptosis according to some, 60, 61 but not all investigators. 62, 63 neoplastic disease resulting from an acquired mutation in a single multipotent hematopoietic stem cell. 15, 24, [32] [33] [34] [35] [36] [37] The Before methods were available to measure cell kinetic parameters quantitatively, most observers assumed as an article of bcr/abl fusion gene is probably the usual sole initial causative event and is responsible for all the manifestations of the early faith that the leukemic cells proliferated more rapidly than their normal counterparts. However, essentially all kinetic chronic phase of the disease. 38, 39 The primary 9;22 translocation somehow induces further genetic instability, and substudies performed during the chronic phase of CML have shown that, on average, while the DNA synthesis time of both clones with additional secondary genetic abnormalities arise. One or more these subclones, which have lost their capacity blood and marrow myelocytes in CML is about the same as that of normal marrow granulocyte precursors, 64,65 the leuto mature, eventually becomes dominant, giving rise to the accelerated or blastic phase of the disease. 40 kemic precursors have lower mitotic indices, a smaller fraction of cells in DNA synthesis, longer generation times, and Chronic phase CML is an excellent model of an early form of human neoplasia due to a single acquired genetic abnorlonger transit times in the maturation compartments than do comparable normal precursors (reviewed in Ref. 39 ). Howmality. CML has often served as an exemplar of human neoplasia in the past, and more complete understanding of its ever, the proliferative parameters return towards normal when the leukocyte count is reduced by treatment 66, 67 and no conpathogenesis may have broad applicability in understanding other early human neoplasias. The Philadelphia chromosome sistent difference in proliferation between normal and CML progenitors are found in vitro. 39, 68, 69 Thus it is likely that the was the first example of a specific cytogenetic abnormality consistently associated with a human neoplasm, and for more slower proliferative parameters found in vivo are probably related to the high cell density of the CML marrows and that than a decade after it was discovered it remained the only example. However, rather than being unique as many investithe cell cycle parameters are similar at comparable cell densities. gators originally supposed, CML pointed the way to general verification of the somatic mutation theory of cancer. 38, 39 Following the development of improved cell culture and high resolution banding methods numerous additional tumorLife span and programmed cell death specific cytogenetic abnormalities have been found, and the evidence is now quite compelling that all human tumors have Using a variety of isotopic labeling procedures, it has been found consistently that the mature granulocytes in chronic one or more specific genetic defects, although, of course, many are not visible microscopically and can only be phase CML have a markedly slower rate of disappearance from the blood than do normal mature granulodetected by molecular methods of analysis.
cytes. [57] [58] [59] [70] [71] [72] [73] [74] [75] [76] [77] Interpretation of the slow granulocyte disappearance rate in CML is confounded by the presence of many circulating immature granulocytes, by the abnormal granuloTheories to explain myeloid expansion cyte traffic and distribution patterns, and by the premature release of incompletely mature segmented neutrophils into the While the underlying genetic abnormality in CML is now quite well defined, the critical biochemical aberrations caused by blood from the marrow and spleen in CML. 38, 39, 67, [73] [74] [75] [76] [77] [78] [79] [80] [81] Although the complexity of the system and limitations of the p210 bcr/abl that can result in the expansion of the myeloid compartment are still largely unknown. Until the middle of data do not permit calculation of precise values, these studies strongly suggest that CML mature granulocytes have a signifithe present century, the original suggestion that CML might be some type of 'suppurative' or infectious disease was seriously cantly increased life span, but that this is not of sufficient magnitude to account solely for the huge expansion in the graconsidered; as recently as 1947, the leading Textbook of Medicine was still hedging as to whether leukemia was an nulocyte mass in CML and that therefore production of granulocytes must also be substantially increased. infectious or neoplastic disease. 41 The seminal observations that viruses can cause tumors in chickens were made over Once committed to differentiation, all hematopoietic cells have finite life spans and normally undergo programmed cell 85 years ago, 42, 43 and beginning in the 1950s, the infectious hypothesis was revitalized in modified form with the demondeath at prescribed times depending on the lineage and environmental factors. [82] [83] [84] [85] There are numerous reports demstration that viruses can cause cancer in rodents, cattle, cats and other animals [44] [45] [46] [47] and by numerous reports of the occuronstrating that apoptosis is inhibited under a variety of conditions in cell lines expressing p210 bcr/abl , [86] [87] [88] [89] [90] [91] [92] in v-abl-transrence of 'clusters' of human leukemia. 48, 49 However, despite an intensive world-wide search and the clear demonstration fected cells with activated tyrosine kinase activity, 93 as well as in progenitors and granulocytes obtained directly from CML that both DNA and RNA viruses can induce leukemia and other neoplasms in experimental systems, [50] [51] [52] [53] [54] no virus has yet patients. 60 Bedi et al 60, 61 have suggested that reduced programmed cell death may be the primary mechanism responbeen identified that causes the usual sporadically occurring cases of acute leukemia or CML. Moreover, except for the sible for expansion of the leukemic clone in CML. On the other hand the older cytokinetic data cited above strongly sugendemically occurring leukemias/lymphomas that are presumably caused by Epstein-Barr virus (EBV) or the human T cell gests that prolonged life span cannot solely account for the expansion of the CML population, and, moreover, other leukemia virus (HTLV-I), extensive epidemiological studies reports have not supported apoptosis as being the main mechties that characterize the disease. Our prior studies have shown that increased cell production in the intermediate and anism responsible for the myeloid expansion. 62, 63 later maturation compartments is responsible for a major portion of the myeloid expansion in CML, but that the initial expansion originates in a primitive progenitor cell compartMorphologic, biochemical and functional changes ment. 38, 39, 68, 69, [109] [110] [111] [112] [113] In this brief review, we will show representative experimental data to illustrate some of the most It must also be recognized that delayed apoptosis alone cannot explain all the other abnormal features that have been prominent and consistent biological abnormalities in CML, and then present a tentative biochemical explanation that can observed in CML such as the aberrant lineage distribution, frequent basophilia, asynchronous maturation of the nucleus account for all the abnormalities including the enormous myeloid expansion. and cytoplasm [94] [95] [96] [97] [98] [99] [100] cells are not found in normal subjects and are thought to demonstrate lineage infidelity in CML. As the disease undergoes The first patient was a previously untreated 16-year-old young woman who presented with progressive weakness and progression to the blastic phase, the incidence and severity of the dysplastic changes increases and the cells develop abdominal discomfort, splenomegaly, WBC 175 000/l, platelets 800 000/l, and hemoglobin 8 g/dl ( Figure 1) . A steradditional abnormalities such as micromegakaryocytes. 103, 107 In the chronic phase of the disease the leukemic cells retain nal aspirate showed a hypercellular marrow, a differential consistent with chronic phase CML (1% blasts), and Ph+ marthe capacity to differentiate almost normally, and the biochemical and functional defects exhibited by the leukemic row metaphases. Prior to any treatment, a continuous intravenous infusion of 3 H-TdR was given for 10 days. She was cells are not of sufficient severity to prevent them from carrying out their essential functions in supporting life in the then treated with splenic irradiation, following which she had a hematologic remission lasting 8 months before her disease absence of normal mature cells. Nevertheless, in addition to the kinetic and dysplastic changes noted above numerous relapsed, still in chronic phase. The results of the 3 H-TdR autoradiographic study are shown subtle biochemical and functional abnormalities of the leukemic cells have been described in CML which have been summarized in several recent reviews. 38, 39, 108, 109 Most of these abnormalities appear to be mutually linked, are quantitative rather than qualitative, and tend to return towards normal when the disease is brought into hematologic remission by treatment; many of the abnormalities may simply reflect the premature release of incompletely mature marrow bands and polymorphs into the blood in CML.
Discordant maturation hypothesis
In attempting to correlate the molecular, biochemical and biological changes induced by the bcr-abl protein, it is important to recognize that the biological changes are pleiotropic, usually quite subtle, often interconnected, and that in the aggregate, they cannot all be explained by simply focusing on one mechanism such as dysregulation of the cell cycle, reduced programmed cell death, increased self-renewal of stem cells, or impairment of any single property such as cell adhesion, anchorage-dependence, or responsiveness to natural inhibitory factors. The signaling pathways controlling apoptosis, differentiation, maturation, proliferation and other cell processes are intimately inter-related, and considered in this context, it is quite reasonable to expect that the biological abnormalities would be both pleiotrophic and mutually linked. We have reviewed the multiple biological abnormalities in CML cells that have been well-described in some detail in recent publications and have collectively designated these abnormalities discordant maturation. 38, 39, 109, 110 If the discordant maturation hypothesis is indeed valid, it should provide a comprehensive
Figure 1
Clinical course of a 16-year-old female patient with newly diagnosed chronic phase CML. 74 explanation for all the consistent major biological abnormali- The second illustrative study was carried out in another young woman who presented with Ph+ acute leukemia. She and marrow, that there was continuous cell traffic between those two organs, and that cells rarely divided in the blood.
was asymptomatic until about a month prior to admission when she developed progressive weakness, anorexia, night All the granulocyte precursors were labeled in all three compartments by the end of a week and 99-100% of the mature sweats, exertional dyspnea, abdominal discomfort, and cutaneous ecchymoses. On admission she had a fever of granulocytes were labeled by the end of the 10-day infusion or a few days later. This study demonstrates that essentially 39°C, a massively enlarged spleen, slight hepatomegaly, a large mediastinal mass, sternal tenderness and scattered all the recognizable granulocyte precursors are actively proliferating and is unlike the situation in most patients with acute ecchymoses. Her hematologic parameters are shown in Figure  3 . Following treatment with vincristine and prednisone she leukemia in whom significant numbers of blasts may remain dormant for many weeks or months. 80, 81, [114] [115] [116] [117] [118] [119] [120] [121] [122] had a nearly complete hematologic remission except for slight persistent splenomegaly which lasted about 6 months when The kinetic data in this and other CML patients also demonstrate that the CML precursors generally proliferate more raprelapse occurred rapidly. Karyotypic analysis of the marrow cells both at presentation and relapse showed that the majority idly than in acute leukemia but more slowly than the corresponding normal precursors when the marrow is densely of metaphases had a Ph chromosome and about half of the cells had additional chromosomal abnormalities, not specipopulated, although the proliferative parameters of normal and CML precursors are similar at comparable cell densities.
fied. Unfortunately no chromosome studies were performed during remission so it is not known how many karyotypically The emergence times of labeled non-dividing CML granulocytes (ie metamyelocytes, bands and segmented neutrophils) normal cells were present in the marrow prior to the first relapse. are very similar to comparable normal cells, indicating that the minimum maturation time is approximately normal in
The pulse 3 H-TdR labeling indices (LI) of the marrow lymphoblasts (in vitro) at presentation and again after full relapse CML. 74 However, the disappearance times of labeled cells and
Figure 2
Labeling pattern of granulocyte precursors and mature granulocytes in a young woman with newly diagnosed chronic phase CML during and after a continuous intravenous infusion of 3 H-thymidine for 10 days. 'Segmented' includes all polymorphonuclear neutrophils with two, three and four segments.
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Figure 3
Clinical course of a newly diagnosed young woman with Ph+ ALL at her initial presentation and at time of her first relapse.
114
(28 October) were consistently low (4.8 to 5.9%) whereas of which appeared to be leukemic; the most recent previous marrow on 17 September had only 1% blasts. After relapse immediately after induction of remission when the marrow only contained 1.5% blasts (22 April), the LI had risen to 23% was first detected on 7 October, the disease progressed quickly; the spleen enlarged rapidly, and numerous blasts ( Figure 3 ). Based on their morphological features as previously described, 114 10.8% of the 1.5% 'blasts' on 22 April were appeared in the marrow and blood ( Figure 3) . A continuous intravenous infusion of 3 H-TdR was started on 13 October and classified as leukemic lymphoblasts and their LI was 5.5% whereas the LI of the other 89.2% 'normal' blasts was 26%; continued for 8 days. No treatment was given for 7 days after ending the infusion when vincristine and prednisone were most of the latter appeared to be myeloblasts with possibly some early pronormoblasts.
started, the latter initially in a dosage of 100 mg/day. Except for arresting the rising number of circulating blasts there was After induction of remission, the patient was treated with a variety of drugs. 114 The first evidence of relapse was noted on no noticeable improvement, and it was not until the dose of prednisone was increased to 5 g/day followed by arabinosyl-7 October when 15% blasts were found in the marrow, most cytosine and splenic irradiation that a second remission was times of the leukemic cells and normal lymphocytes (not shown), prednisone had little effect on the halving time of the reinduced. This only lasted 3 months; there was less and less response to subsequent treatment and the patient died as a granulocyte precursors. 115 Regardless of whether the erythrocyte and granulocyte preresult of extensive leukemic infiltration and multiple complications in November 1965, 13 months after her first relapse.
cursors were normal or part of an (unrecognized) chronic phase leukemic clone, these data provide a striking illustration The results of the 3 H-TdR continuous infusion study during her first relapse are summarized in Figure 4 . The 3 H-TdR of how quickly a relatively slowly proliferating leukemic blast cell population is capable of dominating a granulocyte precurinfusion was started on 13 October, 6 days after reappearance of increased blasts was first noted in the marrow. Essentially sor population growing at about the same rate, as well as replacing a much faster growing erythrocyte precursor popuall the blasts in mitosis were labeled after 1 day, but, consistent with their lower fraction in S phase (ie in vitro pulse 3 Hlation. The high ratio of E1:E4 cells (Table 1) probably reflects curtailment of production beginning at the earliest committed TdR LI = approximately 5.6% vs 20% in previous patient), the interphase leukemic blasts labeled more slowly than the blasts erythroid progenitor cell as a result of inhibition by the rapidly increasing leukemic blasts, 115 rather than an increased numin the chronic phase patient shown earlier in Figure 2 . Nevertheless, after 8 days, 93% of the marrow blasts, 95% of the ber of divisions occurring during maturation as happens in microcytic (eg iron deficiency) anemia. 38, 109, 112 The mechcirculating blasts, and 87% of the blasts in the spleen were labeled. In contrast to the relatively slow labeling of the leuanism of inhibition is unknown, but erythropoiesis was arrested so abruptly that it likely reflects a potent direct effect kemic blasts, the remaining erythroblasts labeled very rapidly, even as the majority of erythroblasts were rapidly disapof acute leukemic blasts in suppressing erythropoiesis rather than a differential response to more generally acting inhibitory pearing as the marrow quickly filled with leukemic blasts ( Figure 4) ; the labeled erythroblasts also disappeared much cytokines such as TGF-␤ or MIP-1␣. 132 The two in vivo kinetic studies summarized in Figures 2 and more rapidly than the leukemic blasts after ending the infusion. 115 4 illustrate several important points about the behavior of CML cells. Chronic phase CML granulocyte precursors have similar Key cytokinetic parameters of the leukemic blasts and erythroblasts are compared in summary form in Table 1 . Virtually cell cycle times but a lower growth fraction, at least at higher cell densities, than corresponding normal precursors. During all the surviving red cell precursors were cycling very rapidly with an estimated average intermitotic time (ie median grain acute transformation one or more subclones arrested at the blastic stage with an even lower growth fraction are capable count halving time) of 19-27 h compared to 85-95 h for the leukemic blasts. 114, 115 After vincristine and prednisone was of rapidly replacing normal or CML chronic phase precursors. The CML chronic phase precursors are capable of fully maturstarted, the latter increased to 195 and 190 h in the marrow and blood respectively; the effect of this treatment on the ing and their rates of maturation are similar to normal. The mature granulocytes have a longer life span than normal but erythrocyte precursors could not be measured since they had already lost their label.
this is not sufficient to account for the huge myeloid expansion in CML. Because of obvious limitations to the types of It is not known for certain whether the erythrocytes and granulocytes were normal or belonged to a chronic leukemic experiments that can be conducted in vivo, it is necessary to turn to in vitro studies to examine finer differences in the bioclone in this patient, but we suspect they were normal. The experiment was performed before methods had been logical behavior of the leukemic and normal cells. developed to permit accurate identification of specific chromosomal rearrangements or othr abnormalities in subpopulations of marrow cells. 10, 40 Ph+ ALL had not yet been Short-term in vitro clonogenic studies comparing normal and CML progenitors defined as a disease entity 123 and it is of course also unknown whether the Ph chromosome was due to a M-bcr or m-bcr breakpoint. Whereas one would expect the erythrocyte and Although hematopoietic cells do not develop entirely normally in any liquid or semi-solid culture conditions so far granulocytic lineages to be part of the leukemic clone if the disease was a blastic phase of CML with an M-bcr breakdevised, their growth and maturation in short-term cultures are sufficiently comparable to that in vivo to provide much point, 32, 34 de novo Ph+ ALL is heterogeneous with respect to the level of commitment of the target cell, both in M-bcr and valuable information. We will summarize some representative results of our in vitro studies comparing the behavior of m-bcr cases. [124] [125] [126] [127] [128] [129] [130] [131] In some cases a multipotent stem cell is the target and the myeloid lineages are involved, whereas in normal and CML progenitors to illustrate the most prominent and consistent abnormalities that have been others the Ph chromosome is restricted to the lymphoid (usually pre-B or C-ALLA) lineage. Paradoxically lymphoidobserved. 38, 39, 68, 69, 74, 81, [109] [110] [111] [112] [113] As noted in the original papers, our findings are generally consistent with those of many restricted cases appear to have a worse prognosis than those arising in a pluripotent stem cell (although both are poor), other investigators. whereas the breakpoint does not seem to affect prognosis. 128, 130 Granulocyte kinetics were also studied 115 (not shown).
Total GM progenitors
There were 47% granulocytes (myelocytes and later forms) on 13 October at the start of the 3 H-TdR infusion, but like the The main hematologic parameters in four newly diagnosed, previously untreated patients with CML in chronic phase are erythrocyte precursors they rapidly decreased to 12% by 28 October. Their labeling pattern was similar to that shown summarized in Table 2 . Patient 1 had the least and patient 4 the most advanced disease while the other two patients were in the first patient including the emergence times of labeled bands and polys and the median grain count halving times of intermediate. All marrow metaphases examined were Ph+ and no additional cytogenetic abnormalities were noted. We commyelocytes (105 h) and metamyelocytes (90 h). While these intermitotic times are similar to that of the leukemic blasts, in pared the clonogenic data in these four patients with those of six healthy normal volunteers who had entirely normal hemacontrast to its effect in prolonging the grain count halving Comparison of labeling pattern of leukemic blasts and erythrocyte precursors in patient with Ph+ ALL shown in Figure 3 during and after continuous infusion of 3 H-thymidine at time of first relapse. 114, 115 tologic parameters; the cell counts of these normal marrows just present some representative examples for illustrative purposes here. 39, 113 were similar (mean, 74 × 10 9 /l) so that the cellularity of the CML marrows ranged from 2.9× normal in patient 2 to Figure 5 shows the 3-and 14-day cloning data in these six normal subjects and four CML patients for the 5.6× normal in patient 4. The methods employed and the results have previously been reported in detail, and we will granulocyte/monocyte (GM) progenitors per 10 6 marrow buffy 
Figure 5
Comparison of 3-and 14-day cloning data for six normal subjects and four newly diagnosed CML patients listed in Table 2 for total GM progenitors per 10 6 marrow buffy coat (BC) cells plated. 39, 113 coat cells. As we have previously shown, the light density Comparison of the sizes of the GM colonies produced by normal and CML progenitors provides additional information fraction of both normal and CML marrow buffy coat cells contain essentially all the progenitors capable of forming CFUon differences in their biological properties. Because none of the 3-day GM colonies, either normal or CML, contained GM and BFU-E colonies of any size, so this fraction was used for assaying the total progenitor population. The CML marmore than 20 cells, the data shown in Figure 6 shows the mean number of 7-and 14-day colonies arranged according rows produced on average 10.3× as many 3-day colonies as the normal marrows per million light density buffy coat cells, to size. While the CML progenitors produced 5.3× and 2.3× the total number of GM colonies per 10 6 buffy coat cells as the but only 2.3× as many 14-day colonies. If one calculates the number of colonies per ml of marrow based on the marrow normal progenitors at 7 and 14 days respectively, the normal progenitors produced about the same number of colonies concell counts in individual CML patients and normal subjects, the differences are even more striking: the 3-and 14-day taining over 100 cells at both time points. If one assumes that all 14-day colonies arose from 3-day colonies that continued CML/normal ratios are respectively 43× and 10×. Comparison of size distribution of 7-and 14-day GM colonies produced by normal and CML total GM progenitors per 10 6 buffy coat marrow cells plated (see Figure 5 ). growing ( Figure 5 ), it can be calculated that 21.4% of the norferentiated while type II blasts show early evidence of granulocytic maturation including non-specific azurophilic granules; mal 3-day colonies grew to Ͼ100 cells at 14 days whereas only 1.8% of the CML 3-day colonies did so. 113 type II blasts cannot be distinguished purely on morphological grounds from early promyelocytes.
The mean percentages of type I and type II blasts in the six enriched normal progenitor populations were 73% type I Enriched GM progenitors blasts and 9% type II blasts, and in the four enriched CML progenitor populations 72% type I blasts and 23% type II During the past 15 years we have used various negative selection and velocity sedimentation procedures to partially or blasts (the remaining cells were diverse cell types which varied in different experiments). Of the total number of type highly enrich subpopulations of normal and CML progenitor cells in order to compare their proliferative characteristics and I blasts initially present in the marrow buffy coat, an average of 68% of the normal type I blasts and 48% of the CML type other properties and determine how they might differ from the total progenitor populations. 68, 69, [109] [110] [111] [112] [133] [134] [135] The progenitors I blasts were recovered in the enriched progenitor populations, but an average of only 7% of the total type II blasts are enriched by negative selection using panels of monoclonal antibodies to remove cells committed to differentiation along (plus early promyelocytes) initially present were recovered in both the normal and CML enriched populations. Based on the any of the major lineages; the enriched lineage-negative (lin−) blast population usually comprises about 0.1-0.7% of the total and differential cells counts of the marrow buffy coat cells and the recovery values cited, the number of progenitors initial marrow buffy coat cells and consists almost entirely of type I blasts plus a few type II blasts or very early promyeloper 10 6 buffy coat cells were calculated; on the average the CML marrows contained 1.8× more type I blasts and 3.6× cytes. In some experiments the enriched progenitors were further separated on the basis of size into primitive intermedimore type II blasts than the normal marrows. This is consistent with all our other morphological, phenotyping, and cloning ate, and late progenitors by velocity sedimentation in an isokinetic gradient. 69, [109] [110] [111] 133 data, and demonstrates that using identical cell separation and enrichment procedures, CML progenitors are more mature Identical cloning experiments using enriched normal and CML progenitors were carried out simultaneously for comparithan comparable normal progenitors. The mean cloning efficiencies (CE) of the enriched normal son with those of the total progenitors shown in Figures 5 and  6 . The relative numbers of types I and II blasts in the enriched and CML GM progenitors was 5.0% and 12.1% respectively, compared to mean CEs of 0.526% and 3.99% respectively for normal and CML progenitor populations are shown in Table  3 . As previously described in detail, 39 type I blasts are undifthe total normal and CML GM progenitors present in the light 
Figure 7
Comparison of 3-and 14-day cloning data for six normal subjects and four newly diagnosed CML patients listed in Table 2 for enriched GM progenitors per 10 6 marrow buffy coat (BC) cells plated. 39, 113 density fraction of the marrow buffy coat. As in the case of and 8), again demonstrating that a lower proportion of CML progenitors are capable of producing large colonies compared the total progenitors, the maximum CE values for both normal and CML enriched progenitors occurred at 3 days. 113 to normal. If the data are presented as the number of 14-day GM colonies produced per 10 4 enriched lin− blasts plated, it Figure 7 shows the number of 3-and 14-day GM colonies produced by the enriched progenitors, calculated per 10 6 can be seen that there is considerable variability and overlap among both normal subjects and CML patients ( Figure 9 ). It buffy coat cells for comparison with the total progenitors shown in Figure 5 . On average, the enriched CML progenitors is well known that cloning efficiencies vary widely among normal donors, and the variability is also probably partly produced 4× as many 3-day colonies as the normal progenitors compared to 10.3× for total progenitors; the reason for attributable to the complexity of the enrichment procedures as well as kinetic differences among individuals. Overall, in this difference is that the CML total progenitor population contains many more later committed progenitors with limited prothis and other studies comparing normal and CML progenitors, 39, 69, 113 and unlike the highly consistent greater cloning liferative potential than the normal total progenitor population, and the majority of these late progenitors are missing efficiency (CE) of more mature CML progenitors in producing 3-day GM colonies, we have found no consistent difference in the enriched populations. The average ratio of 14-day CML/normal colonies was the same (2.3) for the enriched proin the CE of more primitive normal and CML progenitors capable of producing 14-day GM colonies. genitors as for the total progenitors, but there was again considerable variability in the number of 14-day colonies proIn terms of the total numbers of cells generated by the normal and CML progenitors, we have calculated that high produced in different subjects (Figure 7) .
The data on the size of 7-and 14-day colonies produced by liferative progenitors (ie those generating Ͼ100 cells per colony) comprise 24% of the total normal GM progenitors and enriched normal and CML enriched GM progenitors (Figure 8 ) are similar to that of the total progenitors (compare Figures 6 these produce 85% of the GM cells in normal marrow. 113 In Figure 8 Comparison of size distribution of 7-and 14-day GM colonies produced by normal and CML enriched GM progenitors per 10 6 buffy coat marrow cells plated (see Figure 7 ).
Figure 9
Generation of 14-day GM colonies per 10 4 enriched lineage negative blasts plated in six normal subjects and four CML patients to illustrate variability and overlap. 39, 113 contrast, high proliferative progenitors comprise only 2% of taneously, [114] [115] [116] [117] 136 cell cycle analysis of both the normal and CML fractions showed that the percentage of cells in S + G 2 /M the total CML progenitors and these produce only 50% of the CML GM cells. Thirty-five per cent of the normal enriched increases with increasing size of blasts (ie Fx 8: N = 5% and CML = 13%; and Fx 13: N = 52% and CML 45%). 69 progenitor population is comprised of high proliferative progenitors and these produce 90% of the normal GM cells, In the experiments shown here, colony number and size were determined at 14 days. PCR analysis was performed on whereas only 10% of the enriched CML progenitors are high proliferative progenitors and they produce 68% of the CML representative individual GM colonies from CML patients to determine how many might be derived from normal progenicells. Because many more of the CML than normal progenitors with low proliferative potential have been removed by the cell tors. Consistent with our previous experience, 39,137 chimeric bcr/abl mRNA was detected in the great majority of colonies separation procedures, the differences are less marked when comparing highly enriched normal and CML progenitors than derived from CML patients (ie overall 94% of GM colonies were Ph+; rare Ph-negative colonies were found in all three when comparing normal and CML total progenitors. These results emphasize the need to consider the total GM progenifractions).
69,113
The cellular composition of the three pooled fractions tor populations in comparing normal and CML cell production in order to obtain an accurate picture of the cytokinetic abnorobtained from linear Ficoll gradients are shown in lations prior to separation on the gradient were similar (mean % in S + G 2 /M = 21% and 26%, respectively), 69 and these values are also similar to those found in other experiments No consistent differences in expression of c-kit (as identified by the YB5.B8 monoclonal antibody) were observed between with total enriched blast populations. As might be expected and as we have consistently found in previous autoradiothe small, intermediate and large blast fractions, nor between the normal and CML blasts in any of these fractions; 25% or graphic studies in which blast cell size and 3 H-TdR LI 3 H-TdR labeling frequency and intensity were measured simulfewer of the blasts in any of the fractions expressed detectable c-kit. 69 As reported by numerous investigators including ourrequirement than CML for KL plus additional growth factors selves, 69, 112, [138] [139] [140] [141] [142] KL by itself has little effect in stimulating in order to generate the maximum numbers of these large GM colony growth, but acts synergistically with other growth faccolonies. G-CSF alone was sufficient to initiate proliferation tors. In combination with G-CSF, GM-CSF, or both, KL had of the maximum total number of small, primitive (Fx 8) CML the greatest stimulatory effect in increasing both the number progenitors and a mean of 76% of the maximum number of and size of colonies derived from normal primitive and intersmall blast progenitors capable of generating colonies Ͼ100 mediate lin− blasts in Fx 8 and Fx 11. KL had less stimulatory cells ( Figure 12 ). In contrast, comparable normal small, primieffect on the large mature blasts concentrated in Fx 13; there tive blasts in Fx 8 required multiple growth factors (ie KL + was little increase in the total number of GM colonies in Fx G-CSF + GM-CSF) for stimulation of the maximum number 13 but an increased number of larger colonies. The data for and size of colonies ( Figure 10 ). normal Fx 8 and Fx 13 are shown in Figures 10 and 11 ; the Cell counts on pooled GM colonies Ͼ500 cells showed effect of KL on Fx 11 was similar to that on Fx 8 (not shown).
normal colonies had 14 000-30 000 cells/colony while CML In contrast to its major synergistic stimulatory effect on norcolonies had 4000-14 000 cells/colony. 69, 112 All the above mal GM progenitors, KL had very little effect in enhancing the observations are compatible with the conclusion that a greater growth of comparable CML progenitor subpopulations proportion of the CML progenitor subpopulations have (Figures 12 and 13) . Generation of the majority of large (Ͼ500 characteristics associated with a more advanced stage of cells) GM colonies, both normal and CML, required the presmaturation and correspondingly have less proliferative potenence of both G-CSF and GM-CSF which together had a synertial than comparable normal progenitor subpopulations. gistic effect. However, normal progenitors had a greater
Figure 10
Effect of kit ligand (KL) 1000 pmol/l in combination with G-CSF, GM-CSF, and both (each at 400 pmol/l) in stimulating primitive normal progenitors (Fx 8-10) to form GM colonies at 14 days. 
Figure 11
Effect of kit ligand (KL) in combination with G-CSF, GM-CSF, and both in stimulating more mature normal progenitors (Fx 13-17) to form GM colonies at 14 days (see Figure 10 for cytokine concentrations).
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Figure 12
Effect of kit ligand (KL) in combination with G-CSF, GM-CSF, and both in stimulating primitive CML progenitors (Fx 8-10) to form GM colonies at 14 days (see Figure 10 for cytokine concentrations).
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Figure 13
Effect of kit ligand (KL) in combination with G-CSF, GM-CSF, and both in stimulating more mature CML progenitors (Fx 13-17) to form GM colonies at 14 days (see Figure 10 for cytokine concentrations).
Comparison of normal and CML erythrocyte
Thus, like CML GM progenitors, the majority of CML erythrocyte progenitors are also more mature and incapable progenitors and their response to KL of as extensive proliferation as comparable normal erythrocyte progenitors. This conclusion is in accord with the findings of Experiments similar to those conducted for GM progenitors were also conducted to compare the proliferative capacities several other investigators, 143, 144 but one recent report using quite different methodology for estimating proliferative potenof normal and CML BFU-E using the same enriched progenitor populations from normal subjects and CML tial reported that CML BFU-E did not have reduced proliferative capacity. 145 However, the latter studies are not comparapatients. 39, 110, 112, 113 To evaluate their proliferative capacity as quantitatively as possible, the BFU-E colonies were divided ble to ours since KL and other purified growth factors were not used to maximally stimulate the normal cells; one would into four subpopulations (XL = extra large, L = large, M = medium and S = small). Representative colonies were not expect to find the same difference that we observed with suboptimal stimulation. aspirated and cell counts performed on individual XL BFU-E or pooled BFU-E from each of the smaller categories. The approximate mean numbers of cells per BFU-E in different size categories at 14 days were: XL = The foregoing experiments shown above in summary form remain more compact, thus facilitating sizing of colonies since were selected from a large body of experimental data to illusthey only break up into multiple subunits at later culture trate important similarities and differences in the biological times.
behavior of normal and CML progenitors. These similarities Like the GM progenitors, the ratio of more mature erythroand differences have been described in detail in recent cyte progenitors with low proliferative potential to primitive reviews, 38, 39 but can be summarized under four categories progenitors with high proliferative potential is also increased as follows: in CML. However, unlike granulopoiesis, there is no comparable expansion of the erythrocyte population in CML, probably at least in part because enucleation prevents the more mature Morphologic and phenotypic abnormalities progenitors from undergoing additional divisions as takes place in the granulocytic lineage. 109, 110, 112 Chronic phase CML cells retain their capacity for complete In the experiments illustrated here, the normal BFU-E popumaturation, but a greater proportion of CML progenitors have lations were comprised of 21.3% (16-24%) high proliferative premature cytoplasmic maturation than comparable normal BFU-E (XL + L), whereas CML BFU-E populations had only progenitors (eg higher proportions of type II blasts with non-4.7% (4-5%) high proliferative BFU-E (L only; no XL CML specific granules, increased CD33 positivity, higher BFU-E were observed). As a result of this difference, 67% (63-expression of EPO receptors, etc). Despite their ability to 71%) of normal erythroblasts were generated by high proliferundergo near normal maturation, CML chronic phase progeniative BFU-E (L + XL) whereas CML high proliferative BFU-E (L tors and maturing cells may exhibit a number of subtle abnoronly) generated only 17% (13-22%) of CML erythroblasts. 112 malities which tend to increase with disease progression. The CML and normal marrows had similar numbers of BFUThese include ultrastructural evidence of asynchronous matu-E per 10 6 buffy coat cells (mean values 338 and 282, ration of the nucleus and cytoplasm with the latter maturing respectively), but because the majority of CML BFU-E (ie 83%) more rapidly, an increased incidence of dysplastic changes, were only capable of generating small or medium sized colonand appearance of chimeric basophil/eosinophil granules ies, they only generated about 1/3 as many erythroblasts as which are not seen in normal granulocytes. normal (ie CML 3.76 × 10 6 vs N 10.7 × 10 6 cells per 10 6 buffy coat cells). 112, 113 However, because of the increased cell densities of the CML marrows, the numbers of cells generated on Functional abnormalities average per ml of normal or CML marrow are almost equal. These findings are consistent with the clinical observation that at the time of diagnosis the majority of CML patients have Functional abnormalities of developing and/or mature granulocytes include altered motility and chemotaxis, reduced either normal erythrocyte counts or are only slightly anemic, except for patients presenting with very elevated leukocyte phagocytic and bacterial killing activities, and subnormal adhesiveness to glass, nylon, fibronectin, and other stromal counts and more advanced disease (eg Table 2 ). 38, 39 The effects of KL when added to erythropoietin (EPO) alone, elements. Among the various functional abnormalities attributed to Mo T cell-conditioned media (MoCM), and to GM-CSF + IL-3 on the growth of normal and CML BFU-E are shown in Figthe 146 found that bcr sequences not only deregulate ures 14 and 15 respectively. Unlike the pronounced differences in KL's effect on normal and CML early and intermediabl tyrosine kinase, but also activate an actin filament binding function associated with c-abl. They proposed that the normal ate GM progenitors described earlier, normal and CML BFU-E responded similarly to KL. Whereas KL had only a slight or function of bcr is related to maintenance of the cytoskeleton, and that the chimerization of bcr and abl permits abl to bind modest effect in increasing the total number of BFU-E, it caused a marked increased in the size of both normal and to actin microfilaments. Since actin fibers are vital elements involved in maintaining cell shape and in regulating many CML BFU-E. However as highlighted in Figure 16 , the number of large CML BFU-E was far less than the number of large cellular functions and interactions, dysregulation of actin could have a critical role in altering cell growth and matunormal BFU-E and the latter contained twice as many cells on average; moreover no XL CML BFU-E were observed.
ration.
Figure 14
Response of normal BFU-E to kit ligand (KL). Erythropoietin (EPO) 1 unit/ml was added to all cultures initially. KL (1000 pmol/l) was added to EPO alone, to MoT conditioned media (MoCM), and to GM-CSF (400 pmol/l) plus IL-3 (2600 pmol/l) to test its effect in stimulating the total highly enriched normal progenitor population to form BFU-E at 14 days. Medium-sized colonies contained 5000-50 000 cells, large (L) 50 000-100 000; and extra large (XL) Ͼ100 000 cells.
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Figure 15
Response of CML BFU-E to kit ligand (KL); the experimental conditions were identical to those described for Figure 14 .
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Cytokinetic abnormalities duction after exceeding cell densities in the marrow at which cell production normally is reduced more completely The cell cycle parameters of normal and CML chronic phase under steady state conditions. Moreover anomalous cell progenitors and later precursors are similar when the cells are production often takes place in the spleen at a similar rate at comparable cell densities (both in vivo and in vitro). As in to that in the marrow, and sometimes hematopoiesis also other cell populations, the proportions of actively proliferating occurs in other extramedullary sites. The mode of density-CML cells (ie in S + G 2 /M) falls with increasing cell density, dependent inhibition of normal progenitors and the specific and in both normal and CML progenitors the growth fraction abnormalities in CML progenitors that allow them to reach is lower in primitive than in more mature progenitors. The higher-than-normal cell densities are not well understood growth fraction of CML progenitors decreases further after although various explanations have been proposed blastic transformation. Crucial kinetic abnormalities in CML (reviewed in Ref. 39 ). include:
• Unlike normal hematopoiesis, in CML large numbers of immature cells are released into the blood from the marrow, • The normal lineage apportionment is unbalanced with disspleen and sometimes other sites, and continuous cell traffic proportionate committal to granulopoiesis and thrombooccurs between these sites of production. Except in patients poiesis.
with extreme leukocytosis, the cells rarely divide in the • CML mature granulocytes have prolonged life spans and cirblood, but must return to the marrow or spleen to undergo culation times compared to normal cells, but the magnitude mitosis. However, a significant fraction of immature CML of the differences is not sufficient to account for the enorprecursors in S phase are released into the blood. As in mous expansion of the granulocyte compartment; increased acute leukemia, the S phase fraction of the circulating blasts production is also required.
• In CML there is a failure to adequately curtail cell proand later precursors is usually lower than that in the marrow
Figure 16
Effect of kit ligand (KL) in stimulating growth of large (L) and extra large (XL) normal and CML BFU-E at 14 days. The mean numbers of cells in the large normal and CML BFU-E colonies were 94 000 and 46 000 respectively and in the XL normal 211 000 (129 000-431 000); no XL CML BFU-E colonies were found. The experimental conditions are as described for Figure 14 with EPO added initially. 112 except in patients with very elevated WBC when it may be Biochemical abnormalities the same or even higher due to release of cells in S phase Biochemical abnormalities reported in CML cells include low from grossly enlarged spleens. The abnormal release of neutrophil alkaline phosphatase (NAP) activities, subnormal immature cells into the blood has variously been attributed lactoferrin and lysozyme contents, hypersialylation of memto space limitations and overcrowding in the marrow, to brane protein, reduced total gangliosides and neutral glycodecreased adherence to stromal elements, to increased sphingolipid content of the cell membrane, and quantitative motility or invasiveness or to some combination of these changes in granule and other cellular proteins and in memfactors.
brane constituents (reviewed in Refs 38, 39, 108 and 109).
• In accord with their more advanced state of maturation, the Many of the biochemical and functional abnormalities in CML ratio of more mature progenitors with limited proliferative cells appear to be mutually linked, quantitative rather than potential to primitive progenitors with high proliferative qualitative, and probably reflect different maturation stages of potential is substantially increased in chronic phase CML normal and CML cells; they tend to return towards normal compared to normal progenitors; this results in the majority when the disease is brought into remission by treatment. of CML cells being generated by more mature progenitors Recently we have reported constitutive tyrosine phosphorylwhich are no longer under tight regulatory control.
ation of a number of phosphotyrosyl (P-tyr) proteins in early • Whereas a number of human cell lines expressing CML progenitors that are not detectable or are phosphorylated p210 bcr/abl are growth factor independent, like normal proat a greatly reduced level in comparable normal progenigenitors, primary CML progenitor cells are absolutely tors 147-149 as we will describe in more detail below. dependent on hematopoietic growth factors for survival, proliferation, differentiation and maturation. However, we have found certain differences in the response of normal Differences in protein tyrosine phosphorylation in normal CML progenitors to cytokine stimulation which we believe and CML progenitors and correlation with biological may be important in understanding their abnormal abnormalities behavior.
Because of the probable causal relationship between consti-CML GM progenitors are less responsive than normal GM protutive p210 bcr/abl protein tyrosine kinase activity and the manigenitors to the synergistic effect of KL in combination with festations of chronic phase CML, we initiated studies in priother cytokines, especially in increasing the size of colonies mary primitive lineage negative (lin−) chronic phase CML produced by primitive progenitors with high proliferative progenitors and comparable normal lin− primitive progenitors potential. As a corollary, normal primitive GM progenitors to identify differences in proteins constitutively phosphorylhave a much higher requirement tham comparable CML GM ated on tyrosine. We subsequently reported a prominent 62 progenitors for the synergistic effect of KL with other cytokines kDa P-tyr protein that is constitutively phosphorylated in in causing an optimal proliferative response; conversely, CML chronic phase CML primary primitive blasts whose tyrosine progenitors have a reduced requirement for multiple growth phosphorylation is greatly reduced in comparable unstimulated normal blasts. 147 We established 147,148 that this P-tyr p62 factors including KL to attain their maximal response.
protein associates with GAP and is not immunologically primitive lin− normal blasts in response to various hematopoietic cytokines, we found a striking similarity in the phosrelated to the RNA binding GAP-associated p62 protein previously identified by Wong et al 150 which is now referred to phorylation of at least four major (approximately 140, 110, 62 and 55/56 kDa) and at least three minor (approximately 51/53, as Sam 68. 151 Our novel p62 protein (p62 dok ) has now been sequenced and its gene (Dok) cloned; 149 the equivalent 45 and 42 kDa) P-tyr proteins after stimulation with KL and the P-tyr proteins that are constitutively phosphorylated in primurine gene has also now been cloned and is highly homologous to the human gene.
152 p62 dok has no significant homomary primitive lin− chronic phase CML blasts (Figure 19 ). Other growth factors tested (ie GM-CSF, G-CSF, IL-3, FLT3 logy to any existing protein and does not contain any catalytic domain. However, it contains 15 potential tyrosine phosligand, EPO and TPO) were much less active and/or stimulated phosphorylation of other proteins. Thus at least seven phorylation sites, it is proline-rich with 10 PXXP motifs, and sequence alignment studies show it to contain a pleckstrin proteins that are rapidly and transiently phosphorylated on tyrosine in the KL/c-kit signal transduction pathway in lin− homology (PH) domain at its amino-terminus (Figure 17) . Using a rabbit polyclonal antibody raised against a peptide at normal blasts may be constitutive substrates for the p210 bcr/abl activated tyrosine kinase in comparable lin− chronic phase the carboxyl-terminus of p62 dok , we have identified the prominent P-tyr p62 protein in primary CML positive blasts to be this CML blasts.
148,153
Tyrosine phosphorylation is known not only to be important novel protein and have further determined that when tyrosine phosphorylated it does complex with ras-GAP. However, we in transmission of mitogenic signals, [154] [155] [156] but also in transduction of signals regulating differentiation and maturation in have found that the stoichiometry of this complex is rather low and estimate that only a small fraction of total ras-GAP many types of cells, [157] [158] [159] [160] including normal hematopoietic and leukemic cells. [161] [162] [163] [164] [165] [166] [167] With regard to the seven P-tyr prois associated with tyrosine phosphorylated p62 dok . p62 dok appears to be a docking protein that is a major substrate of teins that are rapidly and transiently phosphorylated on tyrosine in the c-kit signaling pathway in primary primitive lin− numerous tyrosine kinases, but its function in different cell types is still uncertain. 149, 152 normal blasts that may be constitutive substrates for the p210 bcr/abl activated tyrosine kinase in comparable chronic The evidence to date suggests that p62 dok is a substrate of the constitutive tyrosine kinase activity of p210 bcr/abl and that phase CML blasts, 148 it is worth noting that KL and bcr/abl have several important similarities in their biological effects it probably functions as a signaling molecule. 149 PH domains are thought to mediate protein-protein interactions and interincluding enhancing survival of early hematopoietic progenitor cells as well as stimulating their expansion (ie KL in synactions with cellular membranes, possibly by binding to inositol phosphate components of the lipid bilayer. If the function ergy with other growth factors). The KL/c-kit receptor system mediates numerous diverse cellular processes in different cell of the PH domain at the N-terminal region of p62 dok is to bind components of the membrane or other proteins, then the C types, including cell proliferation, differentiation, maturation, survival, migration, adhesion to extracellular matrix and terminal portion which contains the majority of tyrosines would likely be positioned to interact with other proteins secretion of cellular proteins. [168] [169] [170] [171] Numerous investigators including ourselves have shown that while KL enhances the within the cytosol. The tyrosines may well be targets for neighboring tyrosine kinases including p210 bcr/abl , and after short-term survival of hematopoietic stem cells and early progenitor cells it has only limited effect by itself on inducing being phosphorylated they could then serve as docking sites for proteins containing SH2 domains. As noted above, p62 dok their proliferation or differentiation. However, when combined with other hematopoietic growth factors, KL can have also contains 10 PXXP motifs which are the core conserved sequence of proline-rich regions recognized by molecules pronounced synergistic effects on proliferation, differentiation, maturation, and distribution. 39, 69, 112, 113, [172] [173] [174] [175] In examining containing SH3 domains. Thus while its true biological function is still unknown, p62 dok has several prominent features the effects of KL on subsets of human progenitor cells, Olweus et al 176 found that KL alone had a greater effect in inducing suggesting it may have an important role in signal transduction networks, probably as a component of a signaling cascade proliferation of erythroid progenitors than GM progenitors and, as we also found, a stronger synergistic effect on primiinitiated by receptor or membrane-associated tyrosine kinases.
In addition to p62 dok , w have detected in whole cell lysates tive than on more mature GM progenitors, but despite these differences there were no differences in expression of the KL the presence of additional clearly consistent but less prominent P-tyr proteins with molecular weights of approximately receptor between the progenitor subsets. Our own studies are generally in accord with the obser-155, 140, 110, 55-56, and 45 kDa as well as more minor Ptyr proteins of approximately 190, 85, 51-53, 42 and 39 kDa vations of most other investigators. In addition, as shown earlier we have found that primitive normal granulothat are constitutively tyrosine phosphorylated in primary primitive lin− chronic phase CML blasts but not, or to a much cyte/macrophage (GM) progenitors are more responsive than comparable CML GM progenitors to KL's synergistic stimulesser extent, in comparable primary lin− normal blasts 148, 153 ( Figure 18 ). We are presently trying to identify and characlatory effect on proliferation and that a higher proportion of CML GM progenitors compared to normal no longer require terize all these P-tyr proteins and to define their inter-relationships in the signaling pathways involved.
KL for a maximum proliferative response. In contrast to the GM progenitors and in keeping with the lesser disturbance of In analyzing proteins tyrosine phosphorylated in primary 
Figure 18
Immunoblot analysis of constitutive P-tyr containing proteins derived from primary primitive lin− normal blasts and Ph+ chronic phase CML blasts. 5 × 10 5 blasts were lysed in hot SDS sample buffer. Cell lysates were separated by 8% SDS-PAGE, immunoblotted with an ␣-P-tyr moAb, developed with the ECL detection system, and exposed to hyperfilm for (a) 1 min and (b) 4 min. Constitutive appearance or enhancement of P-tyr proteins in CML blasts are indicated by arrows on the left and molecular weight standard in kilodaltons (kDa) are indicated on the right.
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Figure 19
Analysis of proteins phosphorylated on tyrosine in response to hematopoietic factors. Primary primitive lin − normal blasts (3-5 × 10 5 ) from three normal donors were exposed for 5 min at 37°C to saturating amounts of growth factors shown. Cells were immediately lysed in hot SDS sample buffer. Cell lysates were separated by 8% SDS-PAGE and immunoblotted with an ␣-P-tyr moAb. The appearance or enhancement of P-tyr proteins, relative to the unstimulated controls, are indicated by arrows on the left and molecular weight markers are indicated on the right. ␣-P-tyr blots were stripped and reprobed simultaneously with ␣-SHC and ␣-GAP antibodies to demonstrate equivalent amounts of proteins in the cell extracts. 148 the erythroid lineage in CML, there is no appreciable differenOur studies also support the view that the primary expansion of the CML population takes place in a primitive progenitial effect of KL on normal and CML erythrocyte progenitors (compare Figures 10-13 with Figures 14-16 ). However higher tor compartment at the time of lineage commitment rather than at the level of earliest self-renewing stem cell. If the latter proportions of both normal GM and erythrocyte progenitors are capable of more extensive proliferation when optimally were true, one would expect an acute rather than a chronic form of leukemia. There are also strong theoretical reasons stimulated than the corresponding CML progenitors; moreover the CML high proliferative early progenitors in both these linwhy the day-to-day fine-tuning regulation of hematopoiesis operates at a later stage than the true (mostly quiescent) stem eages are generally incapable of producing as large colonies as the comparable high proliferative normal progenitors.
cell. It is well established that the majority of normal stem 1422 cells are quiescent in steady state conditions. 38 If large numtors is of course eclipsed in kinetic studies by the subsequent greatly amplified expansion of later progenitor and precurbers of stem cells were simultaneously activated to meet every demand, the system would rapidly become chaotic and ultisor cells. While the model assumes that the initial expansion of the mately break down. Moreover, there is no need to invoke extensive expansion of the stem cell compartment since an CML population begins in primitive committed progenitor cells, it rejects the notion that simple increased self-renewal essential property of both normal and CML stem cells is their enormous self-renewal and repopulating potential. 39 Howin this compartment can by itself explain all the subtle kinetic and other abnormalities that occur in CML cells. One can easever, since there is no reliable in vitro assay to distinguish stem cells from early committed progenitors, it is uncertain ily envisage that if p210 bcr/abl simultaneously induces premature and discordant maturation of early progenitors, the ultiwhether the initial step in the myeloid expansion involves constitutive activation of more stem cells with enhanced input mate proliferative potential of the affected progenitors could well be limited rather than enhanced as would be expected into the early committed progenitor compartment or if the primary expansion begins in this compartment.
if increased self-renewal was the sole mechanism. Thus, in accord with the experimental data cited earlier, a higher proportion of CML later progenitors and precursors have more limited proliferative capacity than the corresponding normal Tentative hypothesis linking biochemical and biological abnormalities cells.
The two models in Figure 21 are intended to compare normal and leukemic granulopoiesis in overview form. The CML In attempting to integrate the biochemical and biological observations, we would like to propose a tentative simple model suggests that one or more extra divisions may take place in a primitive committed progenitor compartment; altermodel comparing normal and CML production. The available evidence so far leads us to postulate that the increased tyronatively, as stated above, one could postulate activation of more stem cells or early progenitor cells. It is implied in the sine kinase activity of p210 bcr/abl causes untimely or inappropriate constitutive tyrosine phosphorylation of a number of model that a smaller fraction of the CML progenitors than normal undergo programmed cell death as indicated by a cross; proteins involved in critical signaling pathways, especially including the c-kit pathway. It is known that sustained actihowever, reduced apoptosis alone cannot explain all the abnormalities such as the dysplastic changes, asynchronous vation of discrete signaling pathways in some types of cells results in differentiation, whereas transient activation is not maturation and aberrant lineage distribution noted earlier. The signaling pathways controlling differentiation, maturation, associated with differentiation but rather leads to a proliferative response; in other cell types, the converse is proliferation, and programmed cell death are closely interconnected, and it is only to be expected that constitutive actiobserved. [177] [178] [179] Different cell types may respond differently depending on prior developmental events such as their convation of one or more of these pathways in a primitive progenitor could serious derange what is normally a highly tent of specific responsive transcription factors.
Thus in CML it may be postulated that the stem cells or integrated and exquisitely coordinated regulatory system. As we have shown, the CML progenitors are slightly more mature primitive committed progenitors are at a particularly susceptible stage of development that renders them especially and on average have less proliferative capacity (as indicated by the number of squiggles) than their normal counterparts, responsive to constitutive, sustained bcr/abl-induced downstream hyperactivation of components of critical regulatory thus resulting in reduced proliferative capacity and a higher proportion of small colonies. Based on cell labeling studies, pathways that are ordinarily activated by low-level, transient extracellular stimulation by KL and other cytokines. The affecit has been known for many years that mature CML granulocytes live longer than normal, thus further contributing to ted short-circuited pathways presumably control and coordinate multiple diverse cell processes including proliferation, expansion of the maturing CML compartments. The control of hematopoiesis is very complex and involves differentiation, maturation and programmed cell death, processes that are normally tightly regulated and highly inteinteraction of multiple cytokines and signaling pathways. Constitutive downstream activation of the c-kit pathway by grated. Perturbation of these key pathways in stem cells or primitive progenitor cells would be expected to seriously disp210 bcr/abl is undoubtedly only part of the story, but it is not yet known what other pathways may be involved. As we have rupt orderly hematopoiesis and could also explain all the subsequent subtle, pleiotropic biological abnormalities characternoted, there are some striking similarities in the protein tyrosine phosphorylation pattern found constitutively in CML proistically observed in later maturing cell compartments that we have collectively designated 'discordant maturation'. 38, 39, 109, 110 genitors and in KL-stimulated normal progenitors, but also some differences. Likewise, as mentioned earlier, while Figure 20 shows a hypothetical model comparing normal granulopoiesis and granulopoiesis in an early stage of chronic bcr/abl and KL/c-kit have some notable similar biological effects such as in enhancing cell survival and expansion, there phase CML, illustrating how either increased activation of stem cells with enhanced input into the primitive committed are also differences. If bcr/abl does in effect cause downstream activation of components of the normal c-kit pathway, it must progenitor compartment, an increased number of divisions in the primitive progenitor compartment, or a reduced fraction be incomplete activation because normal and CML progenitors respond similarly to KL, the main differences being that of cells undergoing programmed cell death can lead to a slight growth advantage and increased cell production. Our own (a) a higher proportion of CML GM progenitors compared to normal no longer require KL for a maximum proliferative data and that in the literature are not sufficiently precise to be able to distinguish between these possibilities, and it is quite response; and (b) greater proportions of both CML CFU-GM and BFU-E are incapable of as great a proliferative response possible that all three mechanisms are operative. Moreover, since the transition from stem cells to primitive multipotent as the corresponding normal progenitors. Using highly purified progenitors and subpopulations of progenitors to the next stages of commitment is undoubtedly a continuum, compartmental distinction in this context is progenitors, we are currently trying to determine more precisely possible differential effects of KL and other cytokines largely arbitrary in any case. The expansion of early progeni-
Figure 20
Hypothetical model comparing primitive GM progenitors in normal granulopoiesis and in early chronic phase CML. Question marks indicate uncertainty about the state of activation of CML stem cells and extent of input into primitive committed progenitor compartment. ⊗ † indicates cells undergoing programmed cell death.
Figure 21
Hypothetical models comparing overview of granulocyte production in normal state and CML. The crosses indicate progenitor cells undergoing apoptosis.
on normal and CML progenitors. We are also trying to define syndromes, multiple myeloma and many other types of cancer also demonstrate close interconnection of maturational, proas precisely as possible the level of progenitor cell development at which the expansion first occurs in CML, and whether liferative and other biological abnormalities. 39 Since each tumor has its own distinctive translocation or other unique the expansion is primarily due to activation of more stem cells or early progenitors rather than additional divisions or genetic lesion, the resultant signaling abnormalities will of course differ, but eventually it should be possible to reach a reduced apoptosis.
We anticipate that more complete understanding of the comprehensive understanding of the specific abnormalities that are responsible for the unique biological properties of pathogenesis of CML may have general significance regarding the pathogenesis of many other types of cancer, and that each type of tumor. In summary, we propose that p210 
